MetLife Management
Management Kriterienprüfungen 3/4
Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.
Wichtige Informationen
Michel Khalaf
Geschäftsführender
US$22.4m
Gesamtvergütung
| Prozentsatz des Geschäftsführergehalts | 6.71% |
| Amtszeit als Geschäftsführer | 7yrs |
| Eigentum des Geschäftsführers | 0.09% |
| Durchschnittliche Amtszeit des Managements | 6.5yrs |
| Durchschnittliche Amtszeit der Vorstandsmitglieder | 6.9yrs |
Jüngste Management Updates
Recent updates
Narrativ-Update • May 03
MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential
Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.Seeking Alpha • Apr 26
MetLife: A Great Time To Buy The Preferred Stock
Summary MetLife preferred shares now yield over 6% as rising rates pressure prices, offering attractive risk/reward for long-term investors. MET's preferred dividends are well covered, with payout ratios under 4% of adjusted earnings and likely dropping to 3% as EPS grows. Series F preferred, MET.PR.F, trades at ~$19.25 for a 6.15% yield. Low payout ratio and strong balance sheet support continued payments. Double-digit adjusted EPS growth and 15–17% ROE guidance suggest MET common shares also offer compelling upside below $80/share. Read the full article on Seeking AlphaNarrativ-Update • Apr 17
MET: Share Repurchases Following Index Exit Will Support Future Upside Potential
Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).Narrativ-Update • Apr 01
MET: Share Repurchases And Index Exit Will Shape Future Upside Potential
Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.Narrativ-Update • Mar 18
MET: Share Repurchases Will Support Future Upside Potential
Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).Narrativ-Update • Mar 04
MET: Buybacks And Retirement Income Agreements Will Drive Future Upside
Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.Narrativ-Update • Dec 16
MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power
Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.Narrativ-Update • Nov 07
MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements
Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.Narrativ-Update • Oct 24
Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead
Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.Narrativ-Update • Oct 09
International Demand And Digital Transformation Will Fuel Success
Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.Narrativ-Update • Sep 04
International Demand And Digital Transformation Will Fuel Success
With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.Analyseartikel • Jun 11
It's Unlikely That MetLife, Inc.'s (NYSE:MET) CEO Will See A Huge Pay Rise This Year
Key Insights MetLife's Annual General Meeting to take place on 17th of June Salary of US$1.50m is part of CEO Michel...Seeking Alpha • Feb 11
MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart
Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking AlphaSeeking Alpha • Nov 26
MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential
Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking AlphaSeeking Alpha • Sep 23
MetLife: One Of The Best Life Insurance Stocks
Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking AlphaSeeking Alpha • Jul 09
Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield
Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking AlphaSeeking Alpha • Jun 26
MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood
Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking AlphaSeeking Alpha • Apr 18
MetLife: Healthy But Lacks Clear Advantages
Summary MetLife has experienced a decade of light shrinking instead of growth. This started as early as 2015 and was attributed to increased competition and a decrease in annuity sales, but this never seemed to improve. With their current size, competitive hurdles, and lack of clear targets for growth internationally, shares of MET will likely only give mediocre returns at best. Read the full article on Seeking AlphaAnalyse der Geschäftsführervergütung
| Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$3b |
| Dec 31 2025 | US$22m | US$2m | US$3b |
| Sep 30 2025 | n/a | n/a | US$4b |
| Jun 30 2025 | n/a | n/a | US$4b |
| Mar 31 2025 | n/a | n/a | US$4b |
| Dec 31 2024 | US$20m | US$2m | US$4b |
| Sep 30 2024 | n/a | n/a | US$4b |
| Jun 30 2024 | n/a | n/a | US$3b |
| Mar 31 2024 | n/a | n/a | US$2b |
| Dec 31 2023 | US$21m | US$1m | US$1b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | n/a | n/a | US$3b |
| Mar 31 2023 | n/a | n/a | US$4b |
| Dec 31 2022 | US$18m | US$1m | US$5b |
| Sep 30 2022 | n/a | n/a | US$5b |
| Jun 30 2022 | n/a | n/a | US$5b |
| Mar 31 2022 | n/a | n/a | US$8b |
| Dec 31 2021 | US$17m | US$1m | US$7b |
| Sep 30 2021 | n/a | n/a | US$5b |
| Jun 30 2021 | n/a | n/a | US$4b |
| Mar 31 2021 | n/a | n/a | US$1b |
| Dec 31 2020 | US$15m | US$1m | US$5b |
| Sep 30 2020 | n/a | n/a | US$6b |
| Jun 30 2020 | n/a | n/a | US$7b |
| Mar 31 2020 | n/a | n/a | US$9b |
| Dec 31 2019 | US$15m | US$1m | US$6b |
Vergütung im Vergleich zum Markt: MichelDie Gesamtvergütung ($USD22.36M) liegt über dem Durchschnitt von Unternehmen ähnlicher Größe auf dem Markt US ($USD14.80M).
Entschädigung vs. Einkommen: MichelDie Vergütung des Vorstandsvorsitzenden entsprach im vergangenen Jahr der Unternehmensleistung.
Geschäftsführer
Michel Khalaf (61 yo)
7yrs
Amtszeit
US$22,364,273
Vergütung
Mr. Michel Abbas Khalaf has been a Director at The Geneva Association since June 10, 2020. Mr. Khalaf has been the President, Chief Executive Officer and Director of MetLife, Inc. since May 1, 2019. He has...
Führungsteam
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO, President & Director | 7yrs | US$22.36m | 0.090% $ 48.8m | |
| Executive VP | 8yrs | US$9.42m | 0.043% $ 23.2m | |
| Executive VP and Head of Global Technology & Operations | 6.5yrs | US$7.92m | 0.0098% $ 5.3m | |
| Executive VP | 14.9yrs | US$6.59m | 0.020% $ 10.6m | |
| Regional President of U.S. Business & Head of MetLife Holdings | 8.7yrs | US$7.92m | 0.028% $ 15.1m | |
| Executive VP & Chief Accounting Officer | less than a year | keine Daten | keine Daten | |
| Senior VP | no data | keine Daten | keine Daten | |
| Executive VP & Chief Legal Officer | 1.3yrs | keine Daten | 0.0027% $ 1.5m | |
| Chief Communications Officer | less than a year | keine Daten | keine Daten | |
| Executive VP & Chief Marketing Officer | 4.5yrs | keine Daten | keine Daten | |
| Executive VP & Chief Human Resources Officer | 1.8yrs | keine Daten | 0.0011% $ 596.7k | |
| President of MetLife Auto & Home and Senior Vice President of Eastern Zone - Individual Business | 19.3yrs | keine Daten | keine Daten |
6.5yrs
Durchschnittliche Betriebszugehörigkeit
53yo
Durchschnittliches Alter
Erfahrenes Management: Das Managementteam von MET ist erfahren und erfahren (durchschnittliche Amtszeit von 6.5 Jahren).
Vorstandsmitglieder
| Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
|---|---|---|---|---|
| CEO, President & Director | 7yrs | US$22.36m | 0.090% $ 48.8m | |
| Executive VP | 5.3yrs | keine Daten | keine Daten | |
| Independent Director | 12.7yrs | US$371.79k | 0% $ 0 | |
| Independent Director | 13.2yrs | US$326.79k | 0.0069% $ 3.8m | |
| Independent Director | 12.3yrs | US$351.79k | 0.0054% $ 2.9m | |
| Independent Director | 1yr | US$213.32k | 0.00044% $ 238.7k | |
| Independent Director | 4.1yrs | US$351.79k | 0.0016% $ 884.1k | |
| Independent Chairman | 19.3yrs | US$606.39k | 0.0012% $ 667.2k | |
| Independent Director | 7.5yrs | US$331.79k | 0.0038% $ 2.1m | |
| Independent Director | 6.8yrs | US$356.79k | 0.0029% $ 1.6m | |
| Independent Director | 3.2yrs | US$326.79k | 0.0014% $ 748.5k | |
| Independent Director | 2.3yrs | US$366.79k | 0.00088% $ 477.3k |
6.9yrs
Durchschnittliche Betriebszugehörigkeit
63yo
Durchschnittliches Alter
Erfahrener Vorstand: METDie Vorstandsmitglieder gelten als erfahren (6.9 Jahre durchschnittliche Amtszeit).
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/22 01:25 |
| Aktienkurs zum Tagesende | 2026/05/22 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
MetLife, Inc. wird von 32 Analysten beobachtet. 9 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Jay Gelb | Barclays |
| Taylor Scott | Barclays |